Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Unilife Corp | d297965d8k.htm |
| EX-99.2 - EXHIBIT 99.2 - Unilife Corp | d297965dex992.htm |
| EX-99.1 - EXHIBIT 99.1 - Unilife Corp | d297965dex991.htm |
Exhibit 99.3
UNILIFE CORPORATION
ARBN 141 042 757
Appendix 4D — Half Year Report
Six months ended 31 December 2011
Results for announcement to the market
UNILIFE CORPORATION HIGHLIGHTS
Results for Announcement to the Market
| Six Months Ended 31 December 2011 US$000’s |
Six Months Ended 31 December 2010 US$000’s |
|||||||||||||||
| Revenues from ordinary activities |
Down | 42.7 | % | to | 3,042 | 5,305 | ||||||||||
| Profit (loss) from ordinary activities after tax attributable to members |
Up | 28.1 | % | to | (22,555 | ) | (17,604 | ) | ||||||||
| Net profit (loss) for the period attributable to members |
Up | 28.1 | % | to | (22,555 | ) | (17,604 | ) | ||||||||
| Dividends (distribution) |
Amount per security | Franked amount per security | ||||||
| Final dividend |
N/A | N/A | ||||||
| Interim dividend |
N/A | N/A | ||||||
| Total |
N/A | N/A | ||||||
| Record date for determining entitlements to the dividend |
N/A | |||||||
Results of Operations
Revenues decreased from US$5.3 million during the six months ended 31 December 2010 to US$3.0 million during the six months ended 31 December 2011. This decrease was primarily attributable to a decline in revenues reflecting the Company’s discontinuance of its contract manufacturing business during the six months ended 31 December 2010.
Net loss increased from US$17.6 million during the six months ended 31 December 2010 to US$22.6 million during the six months ended 31 December 2011. The increase in the net loss was primarily attributable to an increase in research and development expenses related to the development of additional advanced drug delivery systems. These amounts were partially offset by a decrease in non-cash share based compensation expense during the six months ended 31 December 2011 resulting from certain awards that are subject to revaluation as well as a decline in non-research and development payroll expenses.
Basis of the Preparation of the Half Year Report
The half year report has been prepared in accordance with ASX Listing Rule 4.2A.3 and the disclosure requirements of ASX Appendix 4D.
The half year report has been prepared in accordance with accounting principles generally accepted in the United States of America.
The Board of Directors does not recommend that a dividend relating to the six months ended 31 December 2011 be paid. As such, there is no applicable record date.
Net Tangible Assets per Security
| 31 December 2011 | 31 December 2010 | |||||||
| Net tangible assets per share |
US$ | 0.76 | US$ | 0.93 | ||||
| Net tangible assets per CDI |
A$ | 0.13 | A$ | 0.16 | ||||
|
| JIM BOSNJAK Chairman |
Date: 10 February 2012
Half Year Report to 31 December 2011
Unilife Corporation ARBN 141 042 757
2